Analytical Data
-
Gene name
LCT
- Application
-
Alternative Names
LCT；Leukocyte cell-derived chemotaxin-2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P09848
-
Expression Region
全长
-
AA Sequence
full
-
Molecular Weight
218 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LCT (Lactase-Chitosan Technology) recombinant proteins have emerged as a significant focus in biotechnology and pharmaceutical research due to their potential applications in enhancing lactose digestion and improving gut health. Lactose intolerance, which affects a substantial portion of the global population, results from the deficiency of lactase, the enzyme responsible for breaking down lactose into its constituent sugars. This condition can lead to discomfort and digestive issues when dairy products are consumed. The development of recombinant lactase enzymes through biotechnological methods offers a promising solution, as these enzymes can be produced in large quantities with higher purity and efficacy compared to traditional extraction methods. Researchers have increasingly turned to genetic engineering techniques to insert the lactase gene into host organisms, such as bacteria and yeast, which then produce the enzyme in a controllable environment. Furthermore, the stabilization and delivery of these enzymes are critical areas of study, with chitosan—a biopolymer derived from chitin—being explored for its ability to improve enzyme activity and enhance gastrointestinal absorption. The integration of LCT recombinant proteins into dietary supplements and functional foods can potentially alleviate the symptoms of lactose intolerance, thus providing millions of individuals with better access to dairy products while promoting overall gut health. As research advances, the safety, efficacy, and environmental impact of these engineered proteins remain key considerations, paving the way for their future applications in nutrition and healthcare.
